This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Münster. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Michael Schnuerch: Innovator in Cardiomyocyte Research
Introduction
Michael Schnuerch is a notable inventor based in Steinbrunn Neue Siedlung, Austria. He has made significant contributions to the field of cardiomyocyte research, holding two patents that focus on innovative methods for inducing differentiation of mammalian cells.
Latest Patents
Schnuerch's latest patents include "Triazine derivatives as differentiation catalysts" and "Substituted pyridines and pyrimidines." The first patent describes a method of inducing differentiation of mammalian cells into cardiomyocyte-like cells using specific triazine compounds. The second patent provides compounds useful for inducing cardiomyogenesis, which is essential for producing cardiomyocyte-like cells from mammalian cells.
Career Highlights
Michael Schnuerch is affiliated with Technische Universität Wien, where he conducts research and develops innovative solutions in the field of cell differentiation. His work has the potential to impact treatments for heart-related disorders significantly.
Collaborations
Schnuerch collaborates with esteemed colleagues such as Marko Mihovilovic and Karlheinz Hilber, contributing to a dynamic research environment that fosters innovation.
Conclusion
Michael Schnuerch is a prominent figure in the field of cardiomyocyte research, with patents that pave the way for advancements in medical treatments. His contributions are vital for the future of cardiac health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile